World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
45257
World Ranking
9130
National Ranking
4709

Overview

Dan G. Duda is affiliated with Harvard University in the United States and has an extensive research record primarily in medicine and biochemistry, genetics, and molecular biology.

The main fields of study in their work include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Their research encompasses several subfields, notably:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Cancer Research
  • Immunology

Major topics covered in their research are as follows:

  • Cancer Immunotherapy and Biomarkers
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Pancreatic and Hepatic Oncology Research
  • Cancer Mechanisms and Therapy
  • Cancer Genomics and Diagnostics
  • Cancer, Hypoxia, and Metabolism
  • Ferroptosis and cancer prognosis

Recent papers authored or co-authored by Dan G. Duda include:

  • NASH limits anti-tumour surveillance in immunotherapy-treated HCC, 2021, published in Nature
  • The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma, 2020, published in JAMA Oncology
  • Fatty acid synthesis is required for breast cancer brain metastasis, 2021, published in Nature Cancer
  • Combining microenvironment normalization strategies to improve cancer immunotherapy, 2020, published in Proceedings of the National Academy of Sciences
  • Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy, 2022, published in Nature Communications

The scientist frequently publishes in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Cancers

Frequent collaborators include:

  • Rakesh K. Jain
  • Peigen Huang
  • Dai Fukumura
  • Ahmed O. Kaseb
  • Zohreh Amoozgar

Best Publications

  • Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

    Christopher G Willett;Yves Boucher;Emmanuelle di Tomaso;Dan G Duda

  • AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

    Tracy T. Batchelor;A. Gregory Sorensen;A. Gregory Sorensen;Emmanuelle di Tomaso;Wei Ting Zhang;Wei Ting Zhang

  • NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES

    Shom Goel;Dan G. Duda;Lei Xu;Lance L. Munn

  • Angiogenesis in brain tumours

    Rakesh K. Jain;Emmanuelle di Tomaso;Dan G. Duda;Jay S. Loeffler

  • Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.

    Dai Fukumura;Jonas Kloepper;Zohreh Amoozgar;Dan G. Duda

  • Lessons from phase III clinical trials on anti-VEGF therapy for cancer

    Rakesh K Jain;Dan G Duda;Jeffrey W Clark;Jay S Loeffler

  • NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Dominik Pfister;Dominik Pfister;Nicolás Gonzalo Núñez;Roser Pinyol;Olivier Govaere

  • Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

    Yuhui Huang;Jianping Yuan;Elda Righi;Walid S. Kamoun

  • Engineering vascularized tissue

    Rakesh K Jain;Patrick Au;Josh Tam;Dan G Duda

  • Differentiating the pathologies of cerebral malaria by postmortem parasite counts.

    Terrie E Taylor;Wenjiang J Fu;Wenjiang J Fu;Richard A Carr;Richard O Whitten

  • Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

    Apinya Jusakul;Apinya Jusakul;Ioana Cutcutache;Chern Han Yong;Jing Quan Lim

  • Biomarkers of response and resistance to antiangiogenic therapy.

    Rakesh K. Jain;Dan G. Duda;Christopher G. Willett;Dushyant V. Sahani

  • Vascular normalization as an emerging strategy to enhance cancer immunotherapy.

    Yuhui Huang;Shom Goel;Dan G. Duda;Dai Fukumura

  • Malignant cells facilitate lung metastasis by bringing their own soil

    Dan G. Duda;Annique M. M. J. Duyverman;Mitsutomo Kohno;Matija Snuderl

  • HCC and angiogenesis: possible targets and future directions

    Andrew X. Zhu;Dan G. Duda;Dushyant V. Sahani;Rakesh K. Jain

  • Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study

    Christopher G. Willett;Dan G. Duda;Emmanuelle di Tomaso;Yves Boucher

  • Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

    Rakesh R. Ramjiawan;Arjan W. Griffioen;Dan G. Duda

  • Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

    Tracy T. Batchelor;Dan G. Duda;Emmanuelle di Tomaso;Marek Ancukiewicz

  • Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

    Andrew X. Zhu;Dushyant V. Sahani;Dan G. Duda;Emmanuelle di Tomaso

  • Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo

    Mark Stroh;John P Zimmer;Dan G Duda;Tatyana S Levchenko

Frequent Co-Authors

Rakesh K. Jain
Rakesh K. Jain Harvard University
Dai Fukumura
Dai Fukumura Harvard University
Andrew X. Zhu
Andrew X. Zhu Harvard University
Tracy T. Batchelor
Tracy T. Batchelor Brigham and Women's Hospital
Jeffrey W. Clark
Jeffrey W. Clark Harvard University
Christopher G. Willett
Christopher G. Willett Duke University
Patrick Y. Wen
Patrick Y. Wen Harvard University
Yves Boucher
Yves Boucher Harvard University
Dushyant V. Sahani
Dushyant V. Sahani University of Washington
Lance L. Munn
Lance L. Munn Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens the door to a variety of rewarding healthcare careers. For those seeking alternative pathways or specializing in emerging health fields, online degree programs can offer flexibility and affordability.

For example, pursuing a health information management bachelor degree online can lead to roles managing patient data and healthcare records, an area that's crucial in today's digitized medical environment.

Those interested in supporting healthcare efficiency can explore medical coding certification cost to learn about streamlined certification and entry into medical billing and coding roles—a fast-growing career option.

Nursing continues to be in high demand. Prospective nurses can start their journey via online nursing programs, while experienced nurses may consider specialized online nurse practitioner programs to advance their practice.

These online degrees and certifications offer flexible options to build a career in health care—whether at the bedside, behind the scenes, or in administration.

Best Scientists Citing Dan G. Duda

Trending Scientists

Recently Published Articles